Diagnostic Accuracy of a Blood-Based Biomarker Panel for Colorectal Cancer Detection: A Pilot Study
2024

Blood Test for Colorectal Cancer Detection

Sample size: 248 publication 10 minutes Evidence: moderate

Author Information

Author(s): Caraballo Elba V., Centeno-Girona Hilmaris, Torres-Velásquez Brenda Carolina, Martir-Ocasio Madeline M., González-Pons María, López-Acevedo Sheila N., Cruz-Correa Marcia

Primary Institution: University of Puerto Rico Comprehensive Cancer Center

Hypothesis

The diagnostic accuracy of a multi-biomarker panel will outperform individual biomarkers in detecting colorectal cancer.

Conclusion

The study found that a combination of blood-based biomarkers improved the accuracy of colorectal cancer detection compared to individual biomarkers.

Supporting Evidence

  • The combination of biomarkers yielded an AUC of 74.4%, outperforming individual biomarkers.
  • Current colorectal cancer screening methods are often invasive, leading to low compliance.
  • Blood-based tests have shown to increase screening uptake by approximately 11% compared to stool-based tests.
  • IGFBP2 was identified as the best-performing individual biomarker in the study.
  • Further research is needed to validate findings in larger, diverse populations.

Takeaway

Researchers tested a blood test that checks for certain markers to see if people have colorectal cancer, and they found that using a mix of these markers works better than just using one.

Methodology

A case-control study involving plasma samples from 124 colorectal cancer patients and 124 healthy controls, evaluating four biomarkers individually and in combination.

Potential Biases

Differences in methodologies and potential variability in biomarker levels could introduce bias.

Limitations

The sample size was relatively small, and variability in blood sample collection and processing could affect results.

Participant Demographics

Participants included 124 colorectal cancer patients and 124 age- and sex-matched healthy controls, primarily Puerto Rican Hispanics.

Statistical Information

P-Value

p<0.001 for mSEPT9 and IGFBP2

Confidence Interval

95% CI: 68.1–80.6%

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/cancers16244176

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication